# A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects

> **NCT06139367** · PHASE1 · UNKNOWN · sponsor: **Chia Tai Tianqing Pharmaceutical Group Co., Ltd.** · enrollment: 40 (estimated)

## Conditions studied

- Biliary Carcinoma

## Interventions

- **DRUG:** TQB3454 tablets

## Key facts

- **NCT ID:** NCT06139367
- **Lead sponsor:** Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06139367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06139367, "A Clinical Trial of TQB3454 Tablets in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06139367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*